View Item 

Show simple item record

How do I allocate blood products at the end of life? An ethical analysis with suggested guidelines
dc.contributor.authorSmith, Lauren B.en_US
dc.contributor.authorCooling, Lauraen_US
dc.contributor.authorDavenport, Robertsonen_US
dc.date.accessioned2013-05-02T19:35:25Z
dc.date.available2014-05-23T15:04:20Zen_US
dc.date.issued2013-04en_US
dc.identifier.citationSmith, Lauren B.; Cooling, Laura; Davenport, Robertson (2013). "How do I allocate blood products at the end of life? An ethical analysis with suggested guidelines." Transfusion (4): 696-700. <http://hdl.handle.net/2027.42/97526>en_US
dc.identifier.issn0041-1132en_US
dc.identifier.issn1537-2995en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/97526
dc.publisherBlackwell Publishing Incen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titleHow do I allocate blood products at the end of life? An ethical analysis with suggested guidelinesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumFrom the Department of Pathology, University of Michigan, Ann Arbor, Michigan.en_US
dc.identifier.pmid22519756en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/97526/1/trf3658.pdf
dc.identifier.doi10.1111/j.1537-2995.2012.03658.xen_US
dc.identifier.sourceTransfusionen_US
dc.identifier.citedreferenceHurst SA, Danis M. A framework for rationing by clinical judgment. Kennedy Inst Ethics J 2007; 17: 247 ‐ 66.en_US
dc.identifier.citedreferenceUS Department of Health and Human Services. The 2009 nationwide blood collection and utilization survey report. Washington, DC: US Department of Health and Human Services, Office of the Assistant Secretary for Health; 2011. [cited 2012 Mar 29]. Available from: URL: http://www.hhs.gov/ash/bloodsafety/2009nbcus.pdfen_US
dc.identifier.citedreferencePereira J, Phan T. Management of bleeding in patients with advanced cancer. Oncologist 2004; 9: 561 ‐ 70.en_US
dc.identifier.citedreferenceMathoulin‐Pelissier S, Salmi LR, Veret C, Demoures B. Blood transfusion in a random sample of hospitals in France. Transfusion 2000; 40: 1140 ‐ 6.en_US
dc.identifier.citedreferenceAsch DA, Faber‐Langendoen K, Shea JA, Christakis NA. The sequence of withdrawing life‐sustaining treatment from patients. Am J Med 1999; 107: 153 ‐ 6.en_US
dc.identifier.citedreferenceAsch DA, Christakis NA. Why do physicians prefer to withdraw some forms of life support over others? Intrinsic attributes of life‐sustaining treatments are associated with physicians' preferences. Med Care 1996; 34: 103 ‐ 11.en_US
dc.identifier.citedreferenceDomen RE, Sazama K. Informed consent: the donor perspective. In: Stowell C, Sazama K, editors. Informed consent in blood transfusion and cellular therapies. Bethesda (MD): American Association of Blood Banks; 2007. pp. 113 ‐ 37.en_US
dc.identifier.citedreferenceWiltbank TB, Giordano GF. The safety profile of automated collections: an analysis of more than 1 million collections. Transfusion 2007; 47: 1002 ‐ 5.en_US
dc.identifier.citedreferenceHelft PR, Siegler M, Lantos J. The rise and fall of the futility movement. NEJM 2000; 343: 293 ‐ 6.en_US
dc.identifier.citedreferenceGonzalez‐Porras JR, Graciani IF, Perez‐Simon JA, Martin‐Sanchez J, Encinas C, Conde MP, Nieto MJ, Corral M. Prospective evaluation of a transfusion policy of D+ red blood cells into D‐ patients. Transfusion 2008; 48: 1318 ‐ 24.en_US
dc.identifier.citedreferenceYazer MH, Triulzi DJ. Detection of anti‐D in D‐ recipients transfused with D+ red blood cells. Transfusion 2007; 47: 2197 ‐ 201.en_US
dc.identifier.citedreferenceYuan S, Davis R, Lu Q, Goldfinger D, Ziman AF. Low risk of alloimmunization to the D antigen in D‐ orthotopic liver transplant recipients receiving D+ RBCs perioperatively. Transfusion 2008; 48: 2653 ‐ 5.en_US
dc.identifier.citedreferenceQuill TE, Cassel CK. Nonabandonment: a central obligation for physicians. Ann Intern Med 1995; 122: 368 ‐ 74.en_US
dc.identifier.citedreferenceChristian MD, Hawryluck L, Wax RS, Cook T, Lazar NM, Herridge MS, Muller MP, Gowans DR, Fortier W, Burkle FM. Development of a triage protocol for critical care during an influenza pandemic. CMAJ 2006; 175: 1377 ‐ 81.en_US
dc.identifier.citedreferencePowell T, Christ KC, Birkhead GS. Allocation of ventilators in a public health disaster. Disaster Med Public Health Prep 2008; 2: 20 ‐ 6.en_US
dc.identifier.citedreferenceDevereaux AV, Dichter JR, Christian MD, Dubler NN, Sandrock CE, Hick JL, Powell T, Geiling JA, Amundson DE, Baundendistel TE, Braner DA, Klein MA, Berkowitz KA, Curtis JR, Rubinson L; Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster. A framework for allocation of scarce resources in mass critical care. Chest 2008; 133: 51S ‐ 66S.en_US
dc.identifier.citedreferenceWhite DB, Katz MH, Luce JM, Lo B. Who should receive life support during a public health emergency? Using ethical principles to improve allocation decisions. Ann Intern Med 2009; 150: 132 ‐ 8.en_US
dc.identifier.citedreferenceBeauchamp TL, Childress JF. Principles of biomedical ethics. New York: Oxford University Press; 2001.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
trf3658.pdf
Size:
60.31KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.